Sharda Cropchem Limited hosted its Q1 FY27 earnings call on July 30, 2026. The company reported a 9% year-on-year revenue increase to ₹1,074 crores, driven by strong performance in NAFTA, LATAM, and rest of the world markets. Gross margins expanded to 36.7%, and EBITDA grew 25% to ₹178 crores, with an EBITDA margin of 16.6%. The company reiterated its FY27 guidance for 10-15% revenue growth.
Sharda Cropchem Reports Strong Q1 FY27 Performance
Sharda Cropchem Limited presented its financial results for the first quarter of FY27 on July 30, 2026. The company announced a 9% year-on-year increase in revenue, reaching ₹1,074 crores. This growth was attributed to robust performance in the NAFTA, LATAM, and rest of the world markets, which showed improved profitability. The company noted a temporary softening in Europe due to distributor stock adjustments amid heatwave conditions, but expressed confidence in future recovery.
Margin Expansion and Financial Highlights
Gross margins saw a significant improvement, expanding by 120 basis points to 36.7%. EBITDA grew by a healthy 25% to ₹178 crores, with the EBITDA margin increasing by 220 basis points to 16.6%. The company remains debt-free with cash, bank, and liquid investments totaling ₹767 crores as of June 30, 2026. Sharda Cropchem reaffirmed its full-year FY27 guidance of 10%-15% revenue growth and gross margins in the range of 35%.
Market Outlook and Regional Performance
The Agrochemical business grew by 8% year-on-year to ₹915 crores, while the non-Agrochemical business saw a 15% increase to ₹159 crores. LATAM continues to be a strong growth engine for the company. While Europe experienced a temporary dip, margins in the region improved. The company also highlighted its commitment to strengthening its long-term growth through sustained investment in its registration pipeline, with 3,016 product registrations as of June 30, 2026.
Future Projections
Looking ahead, Sharda Cropchem anticipates continued revenue growth and aims to maintain its EBITDA margins in the range of 18% to 20% for FY27. The company is focused on its registration pipeline and expects volume growth to be in the range of 5% to 10% for the full year.
Source: BSE
